High sustained virologic response rate after 8 weeks of direct-acting antivirals in cancer patients with chronic hepatitis C virus

Departments of aInfectious Diseases, Infection Control and Employee Health

bGastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Received 26 April 2022 Accepted 14 June 2022

Correspondence to Dr. Harrys A. Torres, Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA, Tel: +1 713-792-6503; fax: +1 713-745-6839; e-mail: [email protected]

留言 (0)

沒有登入
gif